This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Jan;18(1):1-2.

doi: 10.1111/j.1468-1331.2010.03111.x.

'Let's stick together' Adherence to disease-modifying therapies in multiple sclerosis

T Berger

PMID: 20550560
DOI: 10.1111/j.1468-1331.2010.03111.x

Editorial

'Let's stick together' Adherence to disease-modifying therapies in multiple sclerosis

T Berger. Eur J Neurol. 2011 Jan.

. 2011 Jan;18(1):1-2.

doi: 10.1111/j.1468-1331.2010.03111.x.

Author

T Berger

PMID: 20550560
DOI: 10.1111/j.1468-1331.2010.03111.x

No abstract available

PubMed Disclaimer

Comment on

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis.
Devonshire V, Lapierre Y, Macdonell R, Ramo-Tello C, Patti F, Fontoura P, Suchet L, Hyde R, Balla I, Frohman EM, Kieseier BC; GAP Study Group. Devonshire V, et al. Eur J Neurol. 2011 Jan;18(1):69-77. doi: 10.1111/j.1468-1331.2010.03110.x. Eur J Neurol. 2011. PMID: 20561039 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information